Journal
TRENDS IN MOLECULAR MEDICINE
Volume 15, Issue 11, Pages 519-530Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2009.09.003
Keywords
-
Funding
- NIH [CA86335, CA116804, NS053454]
- American Brain Tumor Association
- Goldhirsh Foundation
- Southeastern Brain Tumor Foundation
- Brain Tumor Funders Collaborative
- Georgia Cancer Coalition, Distinguished Cancer Clinicians and Scientists Program
Ask authors/readers for more resources
Cancer propagating cells (CPCs) within primary central nervous system (CNS) tumors (glioblastoma multiforme (GBM), medulloblastoma (IMB) and ependymoma) might be integral to tumor development and perpetuation. These cells, also known as brain cancer propagating cells (BCPCs), have the ability to self-renew and proliferate. BCPCs can initiate new tumors in mice with high efficiency and these exhibit many features that are characteristic of patient's brain tumors. Accumulating evidence suggests that BCPCs might originate from the transformation of neural stem cells (NSCs) and their progenitors. Furthermore, recent studies have shown that NSC surface markers also define BCPCs. Ultimately, treatments that include specific targeting of BCPCs might potentially be more effective at treating the entire tumor mass, translating to improved patient survival and quality of life.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available